Semaglutide (Ozempic, Wegovy, Rybelsus) Market Size, Share & Trends Analysis Report 2025-2035, Competitive Analysis of Novo Nordisk, Eli Lilly, Viking Therapeutics, Lexicon, Biocon, and AstraZeneca

Semaglutide (Ozempic, Wegovy, Rybelsus) Market Size, Share & Trends Analysis Report 2025-2035, Competitive Analysis of Novo Nordisk, Eli Lilly, Viking Therapeutics, Lexicon, Biocon, and AstraZeneca

DUBLIN--(BUSINESS WIRE)--May 23, 2025-

Semaglutide (Ozempic, Wegovy, Rybelsus) Market Trends Analysis and Growth Report 2025-2035: Emerging Markets and Oral Formulations Present New Frontiers for Expansion

Dublin, May 22, 2025 (GLOBE NEWSWIRE) — The “Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2025 – 2035” report has been added to ResearchAndMarkets.com’s offering. The semaglutide industry is experiencing growth, driven by the increasing prevalence of diabetes and obesity…